Literature DB >> 16504763

Cluster model analysis of late rectal bleeding after IMRT of prostate cancer: a case-control study.

Susan L Tucker1, Ming Zhang, Lei Dong, Radhe Mohan, Deborah Kuban, Howard D Thames.   

Abstract

PURPOSE: Cluster models are newly developed normal-tissue complication probability models in which the spatial aspects of radiation-induced injury are taken into account by considering the size of spatially contiguous aggregates of damaged tissue units. The purpose of this study was to test the validity of a two-dimensional cluster model of late rectal toxicity based on maximum cluster size of damage to rectal surface. METHODS AND MATERIALS: A paired case-control study was performed in which each of 9 patients experiencing Grade 2 or higher late rectal toxicity after intensity-modulated radiation therapy of localized prostate cancer was paired with a patient having a similar rectal dose-surface histogram but free of rectal toxicity. Numeric simulations were performed to determine the distribution of maximum cluster size on each rectal surface for each of many different choices of possible model parameters.
RESULTS: Model parameters were found for which patients with rectal toxicity were consistently more likely to have a significantly larger mean maximum cluster size than their matched controls. These parameter values correspond to a 50% probability of tissue-unit damage at doses near 30 Gy.
CONCLUSIONS: This study suggests that a cluster model based on maximum cluster size of damage to rectal surface successfully incorporates spatial information beyond that contained in the rectal dose-surface histogram and may therefore provide a useful new tool for predicting rectal normal-tissue complication probability after radiotherapy.

Entities:  

Mesh:

Year:  2006        PMID: 16504763     DOI: 10.1016/j.ijrobp.2005.10.029

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  [Translational uroradio-oncology].

Authors:  S E Combs; J Debus
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

2.  A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant.

Authors:  Thomas N Eade; Eric M Horwitz; Karen Ruth; Mark K Buyyounouski; David J D'Ambrosio; Steven J Feigenberg; David Y T Chen; Alan Pollack
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-01-22       Impact factor: 7.038

3.  Role of migratory inhibition factor in age-related susceptibility to radiation lung injury via NF-E2-related factor-2 and antioxidant regulation.

Authors:  Biji Mathew; Jeffrey R Jacobson; Jessica H Siegler; Jaideep Moitra; Michael Blasco; Lishi Xie; Crystal Unzueta; Tong Zhou; Carrie Evenoski; Mohammed Al-Sakka; Rajesh Sharma; Ben Huey; Aydogan Bulent; Brett Smith; Sundararajan Jayaraman; Narsa M Reddy; Shekhar P Reddy; Günter Fingerle-Rowson; Richard Bucala; Steven M Dudek; Viswanathan Natarajan; Ralph R Weichselbaum; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

4.  Emerging role of radiation induced bystander effects: Cell communications and carcinogenesis.

Authors:  Rajamanickam Baskar
Journal:  Genome Integr       Date:  2010-09-12

5.  Evaluation of late rectal toxicity after conformal radiotherapy for prostate cancer: a comparison between dose-volume constraints and NTCP use.

Authors:  Raffaella Cambria; Barbara A Jereczek-Fossa; Federica Cattani; Cristina Garibaldi; Dario Zerini; Cristiana Fodor; Flavia Serafini; Guido Pedroli; Roberto Orecchia
Journal:  Strahlenther Onkol       Date:  2009-06-09       Impact factor: 3.621

6.  Spatial rectal dose/volume metrics predict patient-reported gastro-intestinal symptoms after radiotherapy for prostate cancer.

Authors:  Oscar Casares-Magaz; Ludvig Paul Muren; Vitali Moiseenko; Stine E Petersen; Niclas Johan Pettersson; Morten Høyer; Joseph O Deasy; Maria Thor
Journal:  Acta Oncol       Date:  2017-09-08       Impact factor: 4.089

7.  Parametrized rectal dose and associations with late toxicity in prostate cancer radiotherapy.

Authors:  Lynsey J Hamlett; Andrew J McPartlin; Edward J Maile; Gareth Webster; Ric Swindell; Carl G Rowbottom; Ananya Choudhury; Adam H Aitkenhead
Journal:  Br J Radiol       Date:  2015-08-06       Impact factor: 3.039

8.  Current state of the art, multimodality research and future visions for the treatment of patients with prostate cancer: consensus results from "Challenges and Chances in Prostate Cancer Research Meeting 2013".

Authors:  Stephanie E Combs; Jürgen Debus; Günter Feick; Boris Hadaschik; Markus Hohenfellner; Roland Schüle; Jens-Peter Zacharias; Malte Schwardt
Journal:  Radiat Oncol       Date:  2014-11-04       Impact factor: 3.481

9.  Investigating rectal toxicity associated dosimetric features with deformable accumulated rectal surface dose maps for cervical cancer radiotherapy.

Authors:  Jiawei Chen; Haibin Chen; Zichun Zhong; Zhuoyu Wang; Brian Hrycushko; Linghong Zhou; Steve Jiang; Kevin Albuquerque; Xuejun Gu; Xin Zhen
Journal:  Radiat Oncol       Date:  2018-07-06       Impact factor: 3.481

Review 10.  The Role of Machine Learning in Knowledge-Based Response-Adapted Radiotherapy.

Authors:  Huan-Hsin Tseng; Yi Luo; Randall K Ten Haken; Issam El Naqa
Journal:  Front Oncol       Date:  2018-07-27       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.